Dyslipidaemia and its management in patients with type 2 diabetes across the Middle East and Africa: the PACT-MEA study

Back

ESC Professional Premium Access

Dyslipidaemia and its management in patients with type 2 diabetes across the Middle East and Africa: the PACT-MEA study

Session: Risk factors and prevention: lipids (2)

Topic: Drug therapy

Speaker: Assistant Professor H. Sabbour (Abu Dhabi, AE)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Assistant Professor Hani Sabbour

Cleveland Clinic Abu Dhabi, Abu Dhabi (United Arab Emirates)

0 follower

8 more presentations in this session

Hyperlipoproteinemia(a) in coronary artery disease patients: who are patients with very high levels and how do they respond to the PCSK9 antibody therapy?

Speaker: Doctor M. Novakovic (Ljubljana, SI)

Prevalence and outcomes of familial hypercholesterolemia in young patients undergoing coronary bypass surgery

Speaker: Doctor J. Black (Hobart, AU)

Increased triglyceride independently associates with premature structural and functional cardiac damage progression in asymptomatic adolescents: a 7-year longitudinal study

Speaker: Doctor A. Agbaje (Kuopio, FI)

Characterization of lipidic coronary atheroma under control of low-density lipoprotein <1.8 mmol/l and lipoprotein (a) <50 mg/dl in patients with coronary artery disease

Speaker: Doctor D. Shishikura (Takatsuki, JP)

Increased Lipoprotein (a) and familial hypercholesterolemia: a dangerous combination.Data from a 12-year follow-up study

Speaker: Doctor I. Andrikou (Athens, GR)

Access the full session

Risk factors and prevention: lipids (2)

Speakers: Assistant Professor H. Sabbour, Doctor M. Novakovic, Doctor J. Black, Doctor A. Agbaje, Doctor D. Shishikura...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources